Work

Treatment outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) with sarcomatoid and/or rhabdoid (S/R) features after progressive disease (PD) on immune checkpoint therapy (ICT): The MD Anderson Cancer Center experience.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.351

Authors: Andrew Warren Hahn, Paul Vincent Viscuse, Devaki Shilpa Surasi, Tharakeswara Bathala, Andrew James Wiele, Michael W Starbuck, Matthew T Campbell, Amishi Yogesh Shah, Eric Jonasch, Jianjun Gao, Omar Alhalabi, Kanishka Sircar, Nizar M. Tannir, Pavlos Msaouel

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4213352131

Cites:

Cited by: 1

Related to: 10